보도자료

회사뉴스 게시판

Puma Biotechnology and Bixink Therapeutics Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in South Korea

2020-05-07
조회수 1653

Copyright 2020 - BIXINK    |    Terms of Use    |    Contact

서울특별시 강남구 논현로 561 6층 [06125]

6F, 561 Nonhyeon-ro, Gangnam-gu, Seoul 06125, Republic of Korea